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Background: The literature describing neurocognitive function in patients with late-life
depression (LLD) show inconsistent findings in regard to incidence and main deficits.
Reduced information processing speed is in some studies found to explain deficits in
higher order cognitive function, while other studies report specific deficits in memory and
executive function. Our aim was to determine the characteristics of neuropsychological
functioning in non-demented LLD patients.
Methods: A comprehensive neuropsychological battery was administered to a group
of hospitalized LLD patients and healthy control (HC) subjects. Thirty-nine patients
without dementia, 60 years or older meeting DSM-IV criteria for current episode of
major depression, and 18 non-depressed control subjects were included. The patient
group was characterized by having a long lasting current depressive episode of
late-onset depression and by being non-responders to treatment with antidepressants.
Neurocognitive scores were calculated for the domains of information processing speed,
verbal memory, visuospatial memory, executive function, and language. Number of
impairments (performance below the 10th percentile of the control group per domain)
for each participant was calculated.
Results: Nearly half of the patients had a clinically significant cognitive impairment in
at least one neurocognitive domain. Relative to HC subjects, LLD patients performed
significantly poorer in the domains of information processing speed and executive
function. Executive abilities were most frequently impaired in the patient group (39% of
the patients). Even when controlling for differences in processing speed, patients showed
more executive deficits than controls.
Conclusions: Controlling for processing speed, patients still showed impaired executive
function compared to HCs. Reduced executive function thus appears to be the core
neurocognitive deficit in LLD. Executive function seems to be an umbrella concept for
several connected but distinct cognitive functions. Further studies of neuropsychological
functioning in LLD patients are needed to characterize more specific what kinds of
executive impairments patients have. Additional studies of remitted LLD patients are
needed to separate episode-related and persistent impairments.
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NEUROPSYCHOLOGICAL FUNCTIONING IN LATE-LIFE
DEPRESSION
Late-life depression (LLD) refers to the presence of a sig-
nificant clinical depression in individuals over 60 years of
age and is typically defined independently of age at onset
(O’Hara et al., 2006). When studying neurocognition in major
depression, elderly patients should be identified as a sep-
arate group because their age makes them psychobiologi-
cally different from younger individuals (Bryan and Luszcz,
2000). Neurocognition in elderly non-demented patients with
major depression is characterized by considerable heterogene-
ity. According to Butters et al. (2004) and Bhalla et al. (2009)
about 40–60% of non-demented patients with late life depres-
sion can be classified as cognitively impaired after thorough
neuropsychological assessment. However, a considerable number
of LLD patients show no significant sign of cognitive impair-
ment. Cognitive deficits tend to persist in the remitted state
(Bhalla et al., 2006; Köhler et al., 2010), although in a sub-
group of depressed elderly patients with cognitive dysfunction,
cognition may improve somewhat in remitters (Butters et al.,
2000).
Persistent cognitive deficits after remission in patients with
LLD may be related to neurobiological changes, including brain
atrophy and an increased prevalence of white matter hyper-
intensities (Wilkins et al., 2009). There is also increasing evi-
dence for a link between LLD and development of dementia,
included Alzheimer disease (Steffens et al., 2006). Cognitive
deficits in LLD have been associated with increased rates of relapse
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of depression, disability and poorer response to antidepressant
treatment (O’Hara et al., 2006).
The characteristic cognitive profile of this group of patients
and possible mechanisms causing impairment, are topics of dis-
cussion in the literature. In a recent review, Herrmann et al.
(2007) reports that a large proportion of LLD patients suffer from
reduced executive function, processing speed, episodic memory,
and semantic memory. Visuospatial ability, attention and inhi-
bition, working memory and expressive language have also been
observed to be impaired in patients with LLD (O’Hara et al.,
2006). Executive dysfunction has systematically been listed as
the most pronounced deficit among LLD patients (Herrmann
et al., 2007). These findings support the theory put forth by
Alexopoulos et al. (2000) stating that frontostriatal dysfunction
contributes both to the development of LLD and to executive dys-
function. Differences between LLD patients with early and late
onset are frequently not found (Butters et al., 2004; Sheline et al.,
2006).
Although frequently referred to as a unitary function
(Alexopoulos et al., 2000; Butters et al., 2004), executive function
seems to be an umbrella concept for several connected but dis-
tinct higher cognitive functions (Miyake et al., 2000a; Hull et al.,
2008). In accordance with advices to clinicians from Miyake et al.
(2000b), we havemade a composite measure of executive function
to be used in our analysis in order to reduce some of the weak-
nesses in reliability and validity of individual measures. We have
chosen to classify verbal fluency tests as a language domain. Verbal
fluency tests are often listed within the executive function domain,
but have been reported as rather insensitive measures of execu-
tive function (Henry and Crawford, 2005; Rodriguez-Aranda and
Sundet, 2006), and are thus treated separately in our study.
Butters et al. (2004) maintain that reduced information
processing is responsible for more specific neuropsychological
deficits in LLD, including executive dysfunction. Sheline et al.
(2006) also found that slowed processing speed appeared to be
the core deficit in LLD. Nebes et al. (2000) noted that reductions
in processing resources (speed and working memory) appeared
to persist following remission of depression and that these kind
of deficits may be trait markers for LLD. Other cognitive deficits
could be explained by reductions in processing resources. Sexton
et al. (2012) concludes that impairments in executive function or
processing speed were sufficient to explain differences in episodic
memory and language skills in their group of (remitted) LLD
patients. They also found that executive deficits could not be fully
explained by impairments in processing speed.
Our aims are (1) to analyse and describe neuropsychologi-
cal function in LLD patients, and to compare this group with
healthy controls (HCs). We will focus on the domains of infor-
mation processing speed, memory, verbal fluency, and executive
function. Our hypothesis is that depressed patients are charac-
terized by cognitive deficits in all of these domains, but have the
most pronounced deficits in information processing speed and
executive function. (2) We want to examine the incidence of cog-
nitive impairment in LLD patients by calculating the number
of impaired cases in the patient group compared to the con-
trol group. (3) We also want to investigate if a general deficit,
like information processing speed slowing, is a main deficit that
can explain deficits in other more specific cognitive domains,
including memory and executive function.
MATERIALS ANDMETHODS
PARTICIPANTS
Norwegian speaking Caucasian inpatients meeting the DSM-IV
criteria of major depression (single episode, recurring depres-
sion or bipolar disease) during the period 01.09.09 to 20.12.12
were asked to join the study, unless they met the exclusion cri-
teria. The study was approved by the Regional Committee for
Research Ethics (REK) in Norway which included an approval of
the use of ECT as a first-line medical treatment in selected cases.
In this paper we present baseline data from testing of a group
of inpatients that some days after testing was given ECT. They
were also tested after ECT-series and after an additional 3 months.
Inclusion criteria were age 60–85 years old, being hospitalized in
the Department of Geriatric Psychiatry (DGP), Diakonhjemmet
Hospital, and providing a written consent to participate in base-
line testing and later randomization to bifrontal or unilateral
electrode placement in electroconvulsive therapy (ECT). Patients
were excluded if (1) having a Mini Mental State Examination
(MMSE) Score (Folstein et al., 1975) of less than 24 (maximum
30 points), as this could be a strong indication of dementia,
(2) a diagnosis of dementia or other neurodegenerative disor-
der within the follow-up period of 5 months. Patients with clear
signs of cognitive impairment at baseline, were followed especially
closely and underwent an interdisciplinary dementia assessment,
(3) other diagnosis of neurological disorder; e.g., head injury,
stroke or Mb. Parkinson, (4) current or earlier substance abuse,
(5) rapid cycling bipolar disorder, (6) schizophrenia or schizoaf-
fective disorder. Our criteria for participation in the study allowed
patients withmild cognitive impairment (either amnestic or other
type) to be included in the study, because older adults with
depression often present with signs and symptoms indicative of
cognitive impairment (Wilkins et al., 2009). (7) Since the patients
were given ECT-treatment after baseline-testing, there were some
exclusion criteria related to this kind of treatment, e.g., that ECT
has not had any effect in an earlier depressive episode or ECT
treatment during the last 6 months. In order to relate cognitive
function of LLD patients to an age-matched group without a his-
tory of psychiatric illness, we recruited 20 elderly patients from a
recreational center in the community. Eighteen of these patients
had a MMSE score of 24 or better at baseline and were included
as controls.
CLINICAL ASSESSMENT
Clinical assessment at admission was carried out by a
trained psychiatrist (TMB or TLG) who also scored Hamilton
Depression Scale (17-items) (HAM-D 17, Hamilton, 1960).
TMB also assessed all the patients with MINI International
Neuropsychiatric Interview; specifically the MINI-Plus (Sheehan
et al., 1998) before inclusion. He had participated in a structured
training program for MINI-Plus. Patients with a higher score
than 17 points on HAM-D 17 and diagnosis of major depres-
sion according to MINI could be included. Age at onset, num-
ber of previous episodes, other disease parameters and somatic
morbidity were determined by the psychiatrist (TMB or TLG)
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from the clinical interview. A thorough examination of medi-
cal records and scoring of Cumulative Illness Rating Scale for
Geriatric Patients (CIRS-G) (Miller et al., 1992) was also per-
formed. For our purposes, the psychiatric item of the CIRS-G was
excluded. The psychiatrist (TMB) also administered HAM-D 17
and MMSE to controls, evaluated their somatic morbidity with
CIRS-G and ascertained that they did not have a history of any
major psychiatric illness.
NEUROCOGNITIVE ASSESSMENT
Neurocognitive assessment of the patients and controls were car-
ried out by the clinical neuropsychologist (GSD) or a nurse. The
nurse had been trained by GSD in administering the test battery.
Another trained nurse and an occupational therapist had received
training by GSD and they assisted with testing of the HCs. The
test battery was chosen with the main rationale of giving mea-
surements of memory and executive function as a background
for assessing cognitive adverse effects of ECT. Wanting patients
to be motivated to go through testing three times within a period
of about 5 months, we composed a test battery that was com-
prehensive, but not too strenuous, consisting of subtests from
standard test batteries validated for Norwegian use. Learning and
memory was measured using the official Norwegian research ver-
sion of the Hopkins verbal learning test–revised (HVLT-R, Brandt
and Benedict, 2001), and the Brief Visuospatial Memory test–
R (BVMT-R, Benedict, 1997). Information processing speed was
assessed by the Trail Making test part A (Reitan and Wolfson,
1993) and D-KEFS Color Word Interference test part 1 and 2
(CWIT, Delis et al., 2005). Aspects of executive function were
assessed by D-KEFS Tower Test (Delis et al., 2005), the CWIT
part 3 and 4 (Delis et al., 2005) and the Trail Making test part
B (Reitan and Wolfson, 1993). The CWIT part 3 is based on
the Stroop (1935) procedure. Verbal fluency was assessed with
the letter fluency from the D-KEFS battery (Delis et al., 2005)
and the animal naming test (Borowski et al., 1967). The subtest
Vocabulary from the Wechsler Abbreviated Scale of intelligence
(WASI) (Wechsler, 2007) was used as an estimate of premorbid
intelligence. Global cognitive function was assessed by a revised
version of the MMSE by Engedal et al. (1988). Patients who
did not manage the serial subtraction by sevens in MMSE were
not tested with backward spelling, which was assumed to be a
more easy measure of attention (Ganguli et al., 1990). A self-
constructed unpublished “Media questionnaire” consisting of 20
questions was intended for repeated assessments studying retro-
grade amnesia for information presented in the news prior to
treatment (2003–2008). The questionnaire served also as a mea-
sure of general public knowledge among patients and controls.
An adapted version of the Autobiographical Memory Interview–
Short Form (AMI-SF, McElhiney et al., 1997) measuring personal
semantic memories was administered. It is designed for repeated
use after ECT-treatments and measures retrograde amnesia for
autobiographical memories. It is commonly used in ECT-studies,
but has lately been criticized because of weak separation between
normal forgetting over time and retrograde amnesia and lack
of validiation studies (Semkovska and McLoughlin, 2013). We
adapted AMI-SF for older subjects before the start of the study.
After data from the control subjects were collected, we deleted
five items that could not be answered consistently 2 months after
baseline by a majority of healthy elderly. These items seemed to
threaten the validity of AMI-SF as a measure of retrograde amne-
sia. Maximum score in our adapted version is 30 compared to 60
in the original McElhiney et al. (1997) version.
There were little missing data, except for The Trail Making test
part B that was too difficult for 8 patients who gave up before
the task was completed. Results are also missing for two controls
on this test. One patient and two controls did not complete the
CWIT part 1 and 2, three patients and two controls did not com-
plete part 3 and six patients and two controls did not complete
part 4. There are missing scores on the Tower Test for one patient
and one control. In addition, there is one missing score for con-
trols on the Trail Making Test part A and one missing score for
patients on the Animal Naming Test and the Letter Fluency Test.
Our test battery was organized into 5 domains based mainly
on the current knowledge about what each test measures (Strauss
et al., 2006; Lezak et al., 2012). Raw scores were transformed
into z-scores, using the means and standard deviations of the
elderly control sample. The variance in the control group’s scores
was checked and we found no major threat to validity of the
transformed z-scores. Missing scores were replaced with the aver-
age score for the group (patient or control). The z-scores were
then averaged within each neuropsychological area to produce
domain scores. The domain Information processing speed con-
sists of the CWIT part 1 and 2 and the Trail Making test part
A. The domain of Verbal memory consists of 3 scores from the
HVLT-R; total learning, delayed recall and discrimination (recog-
nition). The domain of visuospatial memory consists of three
scores from the BVMT-R; total learning, delayed recall and dis-
crimination. The domain of language consists of scores from two
fluency tests; the animal learning test and the letter fluency. The
executive domain consists of the Trail Making test part B, the D-
KEFS Tower test and the CWIT part 3 (time + errors divided
by two). The CWIT part 3 time and the CWIT part 3 errors
were highly correlated (r = 0.486, p < 0.001), supporting that
the measures are related, although they measure different aspects
of performance. We chose to exclude part 4 of the CWIT from
our analyses. The CWIT 4 was designed to be the most difficult
part of the test (Delis et al., 2005). But several studies question
the validity of the CWIT 4 as an equally or more sensitive test of
executive impairment than the CWIT 3 in clinical groups (Lippa
and Davis, 2010; Savla et al., 2011). In addition, several patients
in our study did not comply with the CWIT 4 at the 3 months
follow-up, although they did at baseline. Including the CWIT 4
within the baseline domain score, would leave us with an exec-
utive function score that could not be used at the follow-up.
Another reason to exclude the CWIT 4 was more missing scores
at baseline. The CWIT 3 time and the CWIT 4 time scores were
highly correlated (r = 0.464, p = 0.001), supporting the expecta-
tion (Delis et al., 2005) that they partly measure the same exec-
utive function (inhibition). Chronbach’s alpha and mean inter
item correlation for domain scores were: Information process-
ing domain (α = 0.72/r = 0.48), Verbal memory (α = 0.85/r =
0.65), Visuospatial memory (α = 0.86/r = 0.70), Executive
function (α = 0.73/r = 0.51), and Language (α = 0.42/r =
0.27). The number of domains (0–5) in which each subject was
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impaired (defined as performing below the 10th percentile of the
control group) was calculated for both groups.
STATISTICAL ANALYSIS
The Statistical Package for the Social Sciences (SPSS Inc., Chicago,
IL; version 20.0) was used. Means and standard deviations are
reported for continuous variables and percentages for categorical
variables. Clinical data were statistically analyzed using conven-
tional descriptive methods and t-tests. Statistical significance was
determined using the 0.05 level and 2-tailed tests of significance.
Dichotomous variables were analyzed with crosstabs with cor-
responding post hoc analyses performed using chi-squares. In
situations where the expected cell frequencies were <5, Fisher’s
exact test was used. Correlation analyses (Spearman) explored
whether neurocognition was associated with demographic vari-
ables or clinical variables. One-way ANCOVAs with age as a
covariate were used to compare the groups on continuous vari-
ables. Multivariate tests were not used on neurocognitive raw
scores because of missing data, especially on the TrailMaking test.
The relative impact on neurocognition by diagnosis of LLD was
investigated by a one way MANCOVA with all 5 neurocognitive
domain scores entered as dependent variables. Age was entered
as a covariate. Then, a MANCOVA with information processing
speed and age as covariates was conducted, investigating whether
variability in neurocognitive function would then be explained by
reduced processing speed. We followed-up significant findings in
the MANCOVAs by single-test analysis of covariance. Effect sizes
are reported as partial eta squared. Bonferroni corrections were
performed by dividing the p-value by number of tests/domains.
Lastly, a comparison of number of cognitive impairments in
depressed patients and controls was done with a Mann–Whitney
U-test.
RESULTS
CLINICAL CHARACTERISTICSOF THE PATIENT GROUP
Demographic and clinical characteristics of the LLD and HC
groups are presented in Table 1. There were no statistically sig-
nificant group differences between the LLD and HC partici-
pants regarding age, education, gender, estimated premorbid IQ
(Vocabulary, WASI), global cognitive function (MMSE), total
medical disease burden (CIRS-G) or vascular burden (CIRS-
G heart and vascular score). There was a 3 year age difference
between groups (p = 0.087) which may represent a possible con-
founder for neurocognitive performance. Group comparisons
were therefore performed with age as covariate.
The majority of patients had a severe unipolar depression
without psychosis, but with somatic syndrome. The mean age of
first depression episode was in the mid-fifties. As a group, the
patients had previously rather few life-time depressive episodes
and few previous hospitalizations, but reported a long mean
duration of the current episode. 46.1% of the patients could be
considered as medication-resistant defined as no clinical response
Table 1 | Characteristics of the study participants.
Characteristic Patients with LLD (n = 39) Controls (n = 18) Test statistics
Age, mean (SD), y 74.5 (7.0) 77.7 (4.7) t55 = 1.7 p = 0.087
Women, No. (%) 22 (56.4) 12 (66.7) χ21 = 0.5 p = 0.463
Education, mean (SD), y 13.2 (2.9) 13.1 (3.1) t55 = 0.1 p = 0.936
Vocabulary (WASI) t -score, mean (SD) 56.3 (7.8) 57.7 (8.2) t55 = 0.6 p = 0.541
MMSE score mean (SD) 27.6 (1.9) 28.6 (1.5) t55 = 1.9 p = 0.064
Media questionnaire, mean (SD)a 28.5 (5.5) 33.1 (5.6) t55 = 3.0 p = 0.005
AMI-SF mean (SD)b 28.7 (2.1) 28.9 (2.3) t55 = 0.3 p = 0.781
HAM-D 17 mean (SD) 26.5 (4.2) 2.3 (2.5) t54 = 22.6 p < 0.001
CIRS-G total score, mean (SD) 5.5 (3.4) 5.3 (2.4) t55 = 0.1 p = 0.887
CIRS-G heart and vascular score, mean (SD) 1.1 (1.1) 1.3 (1.3) t55 = 0.4 p = 0.657
Severe depression according to HDRS-17 (%) 26 (66.7)
Single episode, No. (%) 8 (20.5)
Unipolar depression, No. (%) 25 (64.1)
Bipolar II, No. (%) 6 (15.4)
Psychosis, No. (%) 11 (28.2)
Age of first depression episode, mean (SD), y 55.5 (18.7)
Duration of current episode (weeks) 42.6 (37.4)
Number of adequate trials with antidepressant, this episode (SD) 1.5 (1.0)
Somatic syndrome, No. (%) 37 (94.9)
Number of major depressive episodes lifetime, mean (SD) 2.5 (3.2)
Number of previous hospitalizations in a psychiatric ward (SD) 1.3 (1.8)
Abbreviations: AMI-SF, Autobiographical Memory Interview–short form; CIRS-G, Cumulative Illness Rating Scale–Geriatrics; HAM-D 17, Hamilton Depression Rating
Scale–17 items; LLD, late-life depression; MMSE, Mini Mental State Examination; WASI, Wechsler Abbreviated Scale of Intelligence.
aSelf-constructed, unpublished. Maximum score is 40.
bModified for use in this study. Maximum score is 30.
Frontiers in Psychology | Cognition June 2013 | Volume 4 | Article 381 | 4
Dybedal et al. Neuropsychological functioning in late-life depression
to previous treatment with at least two different antidepressive
agents given in adequate doses over an adequate period of time.
An additional 38.5% had no clinical response to previous treat-
ment with one antidepressive agent given in adequate doses over
at least 4 weeks.
NEUROCOGNITIVE PERFORMANCE
Table 2 presents raw scores on neuropsychological tests. Using
age as a covariate in the statistical analyses of group differences,
Table 2 shows that the differences were reaching the level of nom-
inal significance in six of the 15 single measures. One of the single
measures (Trail Making test part B) remained statistically signifi-
cant after Bonferroni corrections (setting the p-value at 0.003). A
more detailed analysis of performance on the Tower test showed
that the number of correct solved towers were significantly differ-
ent between the groups [F(1, 52) = 10.63, p = 0.002]. There were
no significant differences in how effective patients and controls
were in solving the tower tasks they eventually succeeded with
(moves used on tasks solved / minimum moves needed to solve
these tasks) [Mean efficacy of patients 1.2 (0.3) and controls 1.23
(0.2), F(1, 49) = 1.5, p = 0.229].
Table 3 presents correlations between the raw scores and
demographic variables for the patient group. There were sev-
eral significant correlations between age and neurocognitive
measures, confirming the benefit of using age as a covariate in
further analysis. Correlations between cognitive measures and
depression score show small tomedium effects. Sex and education
levels have modest effects on some tests, while somatic morbidity
shows very small effects.
A one-way between-groups multivariate analysis of vari-
ance was performed to investigate group differences in cog-
nitive function, by domains. The results are shown in
Table 4. Five dependent variables were used; the domain scores
Information processing speed, Verbal memory, Visuospatial
memory, Executive function, and Language. The independent
variable was group (patient vs. controls), age was covariate. There
was a statistically significant difference between LLD patients and
controls on the combined dependent variables [F(5, 50) = 3.7,
p = 0.006, η2p = 0.27]. When analyzing domain scores separately,
Information processing and Executive function reached statistical
significance, using an alpha level of 0.05, with LLD patients per-
forming poorer than controls. After Bonferroni corrections the
executive function domain remains significant.
A second one-way between-groups multivariate analysis of
variance with Information processing speed and age as covari-
ates was performed for the four domain scores Verbal memory,
Visuospatial memory, Executive function, and Language. The dif-
ference between LLD patients and controls remained statistically
Table 2 | Results of ANCOVA tests comparing LLD patients’ and Control subjects’ raw score performance on individual neurocognitive tests∗a.
Test Patients (n = 39) Controls (n = 18) ANCOVAa η2p
F P
INFORMATION PROCESSING DOMAIN
C-W Interference—color namingb 41.9 (10.5) 35.3 (6.3) 7.1 0.011 0.12
C-W Interference—word readingb 27.5 (6.1) 27.6 (5.6) 0.0 0.838 0.001
Trail Making test A 63.4 (21.6) 53.1 (17.9) 5.2 0.027 0.09
VERBAL MEMORY
HVLT-R total learning 21.1 (4.7) 21.9 (5.7) 1.6 0.218 0.03
HVLT-R delayed recall 7.1 (2.7) 7.5 (2.4) 1.2 0.282 0.02
HVLT-R discriminationc 10.7 (1.3) 10.8 (1.3) 0.1 0.714 0.003
VISUOSPATIAL MEMORY
BVMT-R total learning 12.5 (5.7) 14.4 (6.9) 2.9 0.097 0.05
BVMT-R delayed recall 4.8 (2.7) 5.4 (2.5) 1.9 0.180 0.03
BVMT-R discriminationc 4.8 (1.2) 5.2 (1.0) 2.1 0.151 0.04
EXECUTIVE FUNCTION
Tower testb 12.7 (4.1) 15.9 (3.9) 8.1 0.006 0.14
Trail Making test B 191.5 (78.4) 139.4 (61.0) 10.0 0.003 0.19
C-W Interference—inhibition, timeb 100.7 (33.3) 82.8 (22.9) 5.6 0.022 0.10
C-W Interference—inhibition errorsb 3.4 (4.4) 0.9 (1.1) 6.6 0.013 0.12
LANGUAGE
Animal naming test 17.3 (5.5) 18.7 (6.1) 2.8 0.103 0.05
Letter fluency (F, A, S)b 38.4 (12.3) 39.2 (11.4) 0.01 0.931 <0.001
Abbreviations: BVMT-R, Brief Visuospatial Memory Test–revised; C-W interference, Color Word Interference Test (variant of the Stroop test); HVLT-R, Hopkins verbal
learning test–revised.
*Data are given as mean (SD) of conventional scoring method.
aAge is used as a covariate.
bD-KEFS, Delis Kaplan Executive Function System.
cRecognition; number correct minus false positives.
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Table 3 | Pearson correlations between demographical variables and the patients’ neuropsychological raw scoresa.
Neuropsychological test Sex Age Education CIRS-Gb Depressionc
HVLT-R total learning 0.29 −0.26 0.19 −0.07 −0.34*
HVLT-R delayed recall 0.08 −0.25 0.05 0.04 −0.26
HVLT-R discrimination −0.07 −0.10 0.15 0.07 −0.27
BVMT-R total learning 0.39* −0.36* 0.26 −0.02 −0.26
BVMT-R delayed recall 0.33* −0.39* 0.35* −0.04 −0.20
BVMT-R discrimination −0.09 −0.28 0.10 −0.09 −0.21
Tower testd 0.22 −0.25 0.06 −0.05 −0.22
C-W Interference—color namingd 0.04 0.16 0.24 0.03 0.20
C-W Interference—word readingd 0.04 0.15 0.04 0.11 −0.21
C-W Interference—inhibition, timed −0.001 0.30 −0.30 −0.18 0.10
C-W Interference—inhibition, errorsd −0.21 0.23 −0.17 −0.15 0.12
Animal naming test 0.12 −0.37* −0.07 −0.08 −0.08
Letter fluency (F, A, S)d 0.28 0.22 0.33* 0.25 −0.01
Trail Making test part A −0.11 0.29 −0.16 0.09 −0.09
Trail Making test part B −0.20 0.45** −0.24 0.16 0.11
Abbreviations: BVMT-R, Brief Visuospatial Memory Tes–revised; C-W Interference, Color–Word Interference test (variant of the Stroop test); CIRS-G, Cumulative
Illness Rating Scale–Geriatrics; HVLT-R, Hopkins verbal learning test–revised.
aResults are given for patients with LLD (n = 39).
bTotal score.
cHAM-D 17, Hamilton Depression Rating Scale–17 items.
d D-KEFS, Delis Kaplan Function System.
*P < 0.05; **P ≤ 0.01.
Bold values indicate the correlation between HVLT total learning and depression is −0.34 and significant.
Table 4 | Results on MANCOVA tests comparing elderly control
subjects’ and LLD patients’ z-score performance on cognitive
domainsa.
Domain Mean (SD) F(1, 54) p η2p
Information Processing Speedb −0.5 (1.0) 5.9 0.019 0.10
Verbal Memoryc −0.1 (0.9) 1.0 0.318 0.02
Visuospatial Memoryd −0.3 (0.9) 3.0 0.087 0.05
Executive Functione −1.1 (1.2) 17.4 <0.001 0.24
Languagef −0.15 (0.8) 0.9 0.338 0.02
Abbreviations: LLD, late-life depression.
aResults are given for the patients with LLD (n = 39), age is used as a covariate.
bTrail Making test A, D-KEFS C-W Interference test color naming and word read-
ing (average score).
cThree measures from HVLT-R (average score).
d Three measures from BVMT-R (average score).
eTrail Making test B, D-KEFS Tower test, and (C-W interference—inhibition, time
+ C-W interference, inhibition, errors)/2 (average score).
f Animal naming test and D-KEFS Letter Fluency (F,A,S).
significant on the combined dependent variables, F(4, 50) = 2.9,
p = 0.030, η2p = 0.19, as well as the Executive function when con-
ducted separately [F(1, 53) = 10.4, p = 0.002]. After Bonferroni
corrections the executive function domain remains significant.
Investigating the number of impaired cases, we found that the
depressed patients were impaired in more domains than control
subjects (Mann–Whitney U-test, p = 0.05). Table 5 shows that
in the patient group, close to 50% of the patients experienced a
Table 5 | Percentage of Participants Exhibiting Cognitive deficits
(defined as 10th percentil below comparison group) and mean
number of deficits for patients with LLD and controls.











Mean No. of deficits (SD) 1.0 (1.2) 0.3 (0.7)
Abbreviation: LLD, late-life depression.
clinically significant impairment in at least one cognitive domain
compared to approximately 20% of the controls. Figure 1 shows
performance on cognitive domains by LLD patients and controls.
More depressed patients were impaired in the executive domain
(39 vs. 5.6% of controls, χ2 = 6.6, p = 0.010), but the differences
did not reach significance in the other domains.
DISCUSSION
Patients with late-life major depression were characterized by
slower information processing speed and a markedly stronger
degree of executive deficits than non-depressed HCs. When con-
trolling for information processing speed, the difference in the
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FIGURE 1 | Performance on cognitive domains by LLD patients and controls. Impairment is defined as performance below the 10th percentile of the
control subjects. Abbreviation: LLD, late life depression.
domain of executive function remained significant. There were
no statistically significant differences in verbal memory, visuospa-
tial memory or language (verbal fluency) between groups. Our
findings are consistent with others reporting main differences
between such groups on tests of information processing speed and
executive function (Herrmann et al., 2007).
Contrary to the findings reported by Butters et al. (2004),
but in line with Sexton et al. (2012) and Sheline et al. (2006),
we found that deficits in the executive function could not be
fully explained by a general information processing speed deficit.
Such differences between study reports may be partly explained
by the composition of the test battery and how the composite
neurocognitive measures are defined. Even more important is
probably differences between patient groups. The main features
of our inpatient group seem to be different from the outpatient
group of Butters et al. (2004). They studied mainly outpatients
not yet prescribed antidepressants at the time of testing and
50% of the patients experienced their first depressive episode.
The LLD patients in our study were characterized by among
other factors vegetative symptoms, non-responding to treatment
with antidepressants, and a protracted course of current depres-
sive episode. Non-remitters on antidepressants more often show
executive deficits (Steffens and Potter, 2008; Snyder, 2013).
Consistent with the results of Meeter et al. (2011) the patients’
scores on a test that assessed memory for news were lower than
those of controls (Media Questionnaire). In accordance with
Butters et al. (2004), but in contrast to O’Brien et al. (2004), we
did not find significant differences between groups on tests of ver-
bal fluency. We did not find any significant difference between
the groups in the memory domain either, in contrast to what has
been reported by others (Butters et al., 2004; Köhler et al., 2010;
Mesholam-Gately et al., 2012). Our results underline that neu-
rocognitive impairment in non-demented LLD patients does not
necessarily include memory impairment. Given that one out of
several common pathways linking LLD, mild cognitive impair-
ment and at a later stage dementia, may be cerebrovascular disease
and Alzheimer neuropathology (Butters et al., 2008), it is natural
to expect memory impairment at least in subgroups of non-
demented LLD patients. A likely explanation of different results
within the memory domain, are differences in patient and control
populations and in inclusion and exclusion criteria. Butters et al.
(2004) state that they were “using minimal exclusionary criteria
to maximize the heterogeneity among LLD patients, thus permit-
ting evaluation of a range of potential risk factors for cognitive
impairment” (p. 593). Our choice of exclusionary criteria appears
to have been more comprehensive.
In our study, significantly more depressed patients were cog-
nitively impaired than HC subjects. More depressed patients had
executive deficits, but the differences did not reach statistical sig-
nificance in the domains of verbal memory, visuospatial memory,
information processing speed and language. In our study 51.3%
of the LLD patients were unimpaired, vs. 77.8% of the controls.
In comparison, Butters et al. (2004) found that 39% of their LLD
patients and 67.5% of their controls were unimpaired. Common
for the studies is that a substantial part of LLD patients have
cognitive deficits.
The largest effect sizes when comparing LLD patients and
controls were seen on the Tower test and the Trail Making test
part B. These tests are speed-dependent. But in addition they
require executive abilities like mental flexibility, planning and
working memory. Several studies have found that LLD patients
have lower scores on TMT B (e.g., Lockwood et al., 2002;
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O’Brien et al., 2004). Our findings are conservative because we
choose to record lacking capability to carry through the test as a
missing score and not maximum score.
Mood disorders, and in particular depressive disorders, have
been believed to impact overall executive functioning. The Tower
test is regarded as a sensitive test of this domain, but very few stud-
ies have actually examined the effects of mood disorders on Tower
performance (Sullivan et al., 2009). As shown in our study, the
patients were just as effective as controls (total moves/minimum
moves) when working on Tower tasks that they solved, but they
gave up more quickly and solved fewer items. There was also no
difference between groups with regard to rule infractions while
performing the test.
CONCLUSIONS
Non-demented patients with LLD were significantly more cog-
nitively impaired than HCs. Nearly 50% of patients showed
clinically significant impairment (performance below the 10th
percentile of the control group) in at least one of five neu-
rocognitive domains. Approximately 40% of the patients showed
deficits in the domain of executive function and nearly 20% in the
domain of information processing speed, but in other cognitive
domains they were not significantlymore impaired than controls.
When Information processing speed is accounted for, patients
still show deficits in executive function. The Tower Test and the
Trail Making Test part B seem to be especially sensitive tests for
detecting cognitive deficits in LLD-patients. Future studies are
needed to clarify the exact nature of the executive deficits and the
degree of persistence of deficits after successful clinical treatment.
Numerous studies have documented the weaker effect of antide-
pressants in the subgroup of LLD-patients with executive deficits
(Story et al., 2008), but there is a lack of studies on the effect of
ECT-treatment in this group. There are several clinical implica-
tions of our findings. LLD patients ought to be screened routinely
for cognitive impairment at admission at a DGP. Results from
screening tests and in particular frommore detailed neuropsycho-
logical assessment can assist therapists in tailoring treatment and
follow-up to the patients’ individual needs. Realistic expectations
and tailored treatment can hopefully make relapse of depression
after remission less likely.
STRENGTHS AND LIMITATIONS
A strength of our study is the exclusion of patients with sus-
pected dementia or other neurological diseases at admission. By
following up the patients over 5 months after baseline-testing, we
were able to exclude patients who were given a dementia diagnosis
during their hospitalization or follow up period.
Our neurocognitive test battery was comprehensive and
broad-based, especially in the executive domain. Instead of using
just one or two well-known “executive tests,” we created a com-
posite measure consistent with the recommendation in Miyake
et al. (2000b). Our patient population was comparable to other
relevant study populations with regard to education, gender,
estimated IQ and medical morbidity.
There are a number of potential limitations. The control group
is small and cognitive impairment is not the defined 10% across
domains. It varies from 0 to 18%. On the two domains with evi-
dent differences between groups, the percentage of impairment
in the HC group was less than 6%. An additional limitation is
that the size of the patient group is also rather small. The Low N
in the patient group may cause reduced power to detect real dif-
ferences. By reporting effect sizes of group differences, we invite
the reader to decide whether non-significant findings represent
possible effects given larger subject samples. The mean age of the
controls was 3 years older than the patients’ and may have exag-
gerated group differences that were age dependent. This threat to
external validity was addressed by using age as a covariate variable
in group comparisons.
Results from neurocognitive testing could possibly be influ-
enced by the effect of neurotropic medication. This is difficult
to avoid when studying a group of in-patients with mainly
long-standing symptoms of a depressive episode. The domain of
Language showed a rather weak internal consistency. Each test in
this domain should perhaps be separately considered in the later
analysis of adverse effects of ECT on neurocognition in elderly
patients.
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